The intuitive visualization of prostate lesions through high PSMA uptake enables surgeons to efficiently integrate the suspicious regions identified by PSMA PET/CT with real-time ultrasound images during prostate biopsy, thereby facilitating precise, targeted core needle biopsy of the lesions and effectively improving the detection rate of potential prostate malignancies. This evidence concerns the gene FOLH1 and male reproductive organ cancer.